Table of Contents
- Introduction
- Taxonomy and Classification
- Clinical Significance
- Morphology and Microscopy
- Cultural and Growth Characteristics
- Biochemical and Identification Tests
- Pathogenesis
- Virulence Factors
- Epidemiology and Transmission
- Clinical Manifestations
- Laboratory Diagnosis
- Treatments
- Prevention and Control
- Conclusion
- References
Introduction to Fusobacterium nucleatum
- Fusobacterium nucleatum is a Gram-negative, anaerobic bacterium commonly present as part of the normal microbial flora of the human oral cavity.
- It plays an important role in dental plaque formation by helping different bacterial species adhere to and interact with one another, contributing to the development of complex oral biofilms.
- Although it is generally considered a commensal organism, F. nucleatum can act as an opportunistic pathogen under certain conditions.
- It is strongly associated with periodontal diseases and has also been implicated in various oral and systemic infections.
- Beyond oral disease, increasing evidence has linked F. nucleatum with colorectal cancer, where its presence has been associated with tumor development and progression.
- The bacterium has also been associated with adverse pregnancy outcomes, highlighting its potential role in infections beyond the oral cavity.
- Its ability to interact with multiple microorganisms and host tissues makes F. nucleatum an important organism in the study of oral microbiology, systemic infections, and microbiome-associated diseases.
Taxonomy and Classification of Fusobacterium nucleatum
- Domain: Bacteria
- Kingdom: Fusobacteriati
- Phylum: Fusobacteriota
- Class: Fusobacteriia
- Order: Fusobacteriales
- Family: Fusobacteriaceae
- Genus: Fusobacterium
- Species: Fusobacterium nucleatum (F. nucleatum)
Clinical Significance of Fusobacterium nucleatum
- Fusobacterium nucleatum is considered the principal species of clinical significance within the genus Fusobacterium and is among the most frequently studied and commonly isolated species in clinical settings.
- Other medically recognized species include F. necrophorum, F. varium, and F. periodonticum; however, they are less frequently associated with human disease compared with F. nucleatum.
- The clinical importance of F. nucleatum is largely attributed to its involvement in oral and systemic infections.
- It is strongly associated with periodontal disease and has also been implicated in various extraoral infections.
- Increasing research has linked F. nucleatum with colorectal cancer, further highlighting its importance in human health and disease.
- Its ability to participate in polymicrobial communities and interact with host tissues contributes to its role in both localized oral disease and systemic pathological conditions.
Morphology and Microscopy of Fusobacterium nucleatum
- Fusobacterium nucleatum is a Gram-negative, slender rod-shaped bacterium with characteristic tapered, pointed ends.
- Its spindle-shaped morphology gives it a distinctive “needle-like” or “spindle” appearance under the microscope.
- The cells typically measure approximately 0.4–0.7 µm in width and 3–10 µm in length.
- Microscopically, the organisms may occur singly, in pairs, or in short chains.
- F. nucleatum is non-spore-forming, meaning it does not produce bacterial endospores.
- It is non-motile and does not possess structures for active locomotion.
- Some strains may possess a thin capsule, which can contribute to their interaction with the host environment.
- On Gram staining, the organism appears as slender Gram-negative rods with pointed ends, making its characteristic spindle-shaped morphology an important microscopic feature.
Cultural and Growth Characteristics of Fusobacterium nucleatum
- Fusobacterium nucleatum is a strict anaerobe, requiring an oxygen-free environment for optimal growth.
- Optimum temperature: Approximately 35–37°C.
- Optimum pH: Around pH 7.0, which supports growth under near-neutral conditions.
- It grows best on enriched anaerobic culture media supplemented with nutrients required for its growth.
Growth on Blood Agar
- Colonies are typically small, approximately 1–2 mm in diameter.
- Colonies are generally round to slightly irregular, translucent, and may have a smooth surface.
- They are typically non-hemolytic.
- A characteristic “fried-egg” appearance may develop on blood agar.
- Cultures may produce a distinctive foul or rancid odor.
Growth on Brain Heart Infusion (BHI) Agar
- Colonies are usually 1–3 mm in diameter.
- They may be circular, irregular, or have slightly lobate margins.
- Colonies range from grayish-white to cream-colored.
- The surface may be smooth to slightly granular, sometimes described as having a bread-crumb-like appearance.
- Colonies are generally convex to flat with a soft or butyrous (buttery) consistency.
- A foul or rancid odor may be noticeable due to metabolic products.
Growth in Thioglycollate Broth
- F. nucleatum produces diffuse turbidity throughout the broth, accompanied by sediment formation at the bottom.
- Growth is typically associated with the anaerobic portions of the medium, consistent with its strict anaerobic nature.
Biochemical and Identification Tests of Fusobacterium nucleatum
The following biochemical characteristics can be used to support the identification of Fusobacterium nucleatum. Some reactions, particularly carbohydrate fermentation and gelatin hydrolysis, may show strain-dependent variation.
Biochemical and Identification Tests
Carbohydrate Fermentation
Enzymatic Reactions
Pathogenesis of Fusobacterium nucleatum
Initial Colonization in the Oral Cavity
- Fusobacterium nucleatum is commonly found as part of the normal oral microbiota.
- It acts as an important “bridge organism” in dental plaque by connecting early-colonizing bacteria with later-arriving microorganisms.
- This bridging ability allows F. nucleatum to become incorporated into complex polymicrobial biofilms.
Biofilm Formation and Plaque Development
- F. nucleatum contributes significantly to the maturation and development of dental plaque.
- It promotes microbial aggregation through co-adhesion with a wide range of other oral bacteria.
- The resulting biofilm provides protection against host immune defenses and antimicrobial agents.
- As the biofilm develops, oxygen becomes limited, creating an anaerobic environment that supports the growth and persistence of F. nucleatum and other anaerobic microorganisms.
Adhesion and Tissue Attachment
- F. nucleatum uses several adhesins, including FadA and Fap2, to interact with and attach to host cells.
- FadA binds to E-cadherin on epithelial cells, promoting bacterial adhesion and facilitating cellular invasion.
- Fap2 contributes to interactions with host cells and tissues and is involved in bacterial colonization and immune modulation.
- These adhesion mechanisms are important for local oral infection as well as potential systemic dissemination.
Invasion of Host Tissues
- Following attachment, F. nucleatum can invade gingival epithelial cells and interact with deeper host tissues.
- FadA-mediated interactions and manipulation of host-cell signaling and cytoskeletal processes can facilitate cellular entry.
- Tissue invasion can contribute to gingival inflammation, tissue damage, and progression of periodontal disease.
Induction of Inflammation
- Components of F. nucleatum, particularly its lipopolysaccharide (LPS), can activate host immune responses.
- This stimulation promotes the production of pro-inflammatory cytokines, including IL-1, IL-6, and TNF-α.
- Persistent inflammation can contribute to gingival swelling, periodontal pocket formation, and destruction of alveolar bone.
- Chronic inflammatory responses play an important role in the development and progression of periodontitis.
Immune Evasion and Persistence
- F. nucleatum possesses mechanisms that can interfere with host immune responses, including modulation of neutrophil and macrophage activity.
- These mechanisms may reduce effective bacterial clearance and promote long-term persistence within the host.
- Survival within polymicrobial biofilms and, in some circumstances, within host cells can further support chronic infection.
Systemic Dissemination
- In individuals with periodontal disease or disrupted oral tissues, F. nucleatum can potentially enter the bloodstream, allowing dissemination beyond the oral cavity.
- Systemic infections associated with F. nucleatum include liver and brain abscesses and, in some cases, Lemierre’s syndrome.
- The bacterium has also been associated with adverse pregnancy outcomes and has received considerable attention for its relationship with colorectal cancer and colorectal carcinogenesis.
- Its ability to adhere to host cells, invade tissues, modulate immune responses, and persist within microbial communities contributes to its potential for both localized and systemic disease.
Virulence Factors of Fusobacterium nucleatum
Adhesins
RadD
- Promotes coaggregation between different bacterial species and contributes to the formation of multispecies oral biofilms.
- It can also interact with host immune cells and contribute to immune evasion and lymphocyte cytotoxicity.
FadA (Fusobacterium adhesin A)
- Binds to E-cadherin on host epithelial cells.
- Facilitates bacterial adhesion, cellular invasion, and inflammatory responses.
- FadA-mediated interactions are particularly important in F. nucleatum colonization and tissue invasion.
Fap2
- Contributes to adhesion, immune evasion, and interactions with host cells.
- It can interact with tumor-associated cells, making it particularly relevant to research on the association between F. nucleatum and colorectal cancer.
CmpA
- Contributes to bacterial adhesion and coaggregation with Streptococcus gordonii, supporting the development of polymicrobial oral biofilms.
FomA
- An outer-membrane protein involved in bacterial adhesion and coaggregation, including interactions with Porphyromonas gingivalis.
FAD-I
- Has been reported to influence host antimicrobial responses, including enhancement of the expression of human β-defensin-2 (hBD-2).
Outer-Membrane Lectin
- Promotes interspecies aggregation involving organisms such as Treponema denticola and Porphyromonas gingivalis, contributing to polymicrobial biofilm development.
Endotoxins
- The lipopolysaccharide (LPS) of F. nucleatum can stimulate host immune responses and promote the release of pro-inflammatory cytokines, including IL-1 and TNF-α.
- Persistent inflammatory signaling can contribute to gingival inflammation and periodontal tissue destruction.
Proteolytic Enzymes
- F. nucleatum produces proteolytic enzymes that can degrade host proteins and extracellular components.
- These enzymes may contribute to tissue damage, bacterial dissemination, and nutrient acquisition.
Immune Modulation
- F. nucleatum can modulate host immune responses, helping the bacterium evade effective clearance.
- Alteration of immune-cell functions can contribute to bacterial persistence and chronic inflammation.
Biofilm Formation
- Biofilm formation is a major factor supporting the survival and persistence of F. nucleatum.
- Its ability to participate in multispecies biofilms provides protection from host immune defenses and antimicrobial exposure.
- Through coaggregation with other oral microorganisms, F. nucleatum contributes to the development of a complex and stable periodontal biofilm.
Epidemiology, Disease Association, and Transmission of Fusobacterium nucleatum
Global Distribution and Prevalence
- Fusobacterium nucleatum has a worldwide distribution and is found in human populations across different geographic regions.
- It is commonly present as part of the normal oral microbiota, particularly in dental plaque and gingival crevices.
- Beyond its role in oral health, F. nucleatum has attracted increasing attention because of its association with colorectal cancer (CRC) and other systemic diseases.
- Studies from Asian countries, including Japan, Iran, and China, have reported an association between increased detection of F. nucleatum and colorectal cancer.
Association with Colorectal Cancer
- Case-control studies analyzing colorectal tissue and microbial profiles have reported a higher prevalence or abundance of F. nucleatum in CRC patients compared with healthy individuals.
- Meta-analyses have similarly reported an increased presence of F. nucleatum in colorectal cancer tissues, supporting its potential involvement in colorectal disease.
- Research in Brazil has identified increased levels of potentially oncogenic bacteria in colorectal cancer tissues, with Fusobacterium representing an important bacterial genus in tumor-associated samples.
- Studies from China have reported that the detection rate and abundance of F. nucleatum can be higher in carcinoma tissues than in adjacent normal tissues.
- Higher levels of the bacterium have also been detected in high-grade dysplastic lesions, suggesting a possible relationship with the progression of colorectal carcinogenesis.
- Although these findings strongly support an association, the presence of F. nucleatum alone does not establish that it independently causes colorectal cancer; its role appears to involve complex interactions with host cells, inflammation, and the gut microbiome.
Association with Oral Cancer
- F. nucleatum has also been investigated for its potential role in oral squamous cell carcinoma (OSCC).
- Experimental studies suggest that the bacterium may promote the proliferation of oral cancer cells through mechanisms involving the CDH1/E-cadherin–β-catenin pathway.
- In human oral epithelial cell models, exposure to F. nucleatum has been associated with reduced E-cadherin function, increased cellular migration, and increased expression of Snail family transcriptional repressor 1 (SNAI1).
- These changes are associated with features of epithelial–mesenchymal transition (EMT), a biological process involved in cancer-cell migration and invasion.
- These findings suggest that F. nucleatum may contribute to tumor progression, although further research is required to establish the mechanisms and clinical significance.
Relationship with Diet, Lifestyle, and Intestinal Diseases
- Current evidence has not established a consistent relationship between the presence of F. nucleatum in colorectal tumors and specific dietary habits or lifestyle factors.
- Its association with other intestinal conditions, such as ulcerative colitis, is also complex.
- Although F. nucleatum may contribute to gut microbiota dysbiosis and altered microbial metabolism, its precise role in initiating or worsening ulcerative colitis remains under investigation.
Transmission and Dissemination
Endogenous Transmission
- Endogenous spread is considered an important route by which F. nucleatum can cause infection.
- Disease may occur when normal mucosal barriers are disrupted by conditions such as periodontal disease, dental procedures, or oral trauma.
- Following barrier disruption, the bacterium can spread from the oral cavity into adjacent tissues or the bloodstream.
Person-to-Person Transmission
- Because F. nucleatum is part of the oral microbiota, exposure can occur through saliva and close interpersonal contact.
- Potential routes include activities involving saliva exchange, such as kissing or sharing oral items.
- Such exposure may contribute to the establishment and exchange of oral microbial communities, although the clinical importance of direct person-to-person transmission is not fully established.
Vertical Transmission
- F. nucleatum may be transmitted from mother to infant, particularly through exposure during birth or close contact after delivery.
- The bacterium has been detected in association with pregnancy-related complications, and research has investigated its potential ability to reach placental tissues.
- Its association with adverse pregnancy outcomes has raised interest in possible maternal–fetal transmission and systemic dissemination.
Hematogenous Transmission
- F. nucleatum can enter the bloodstream, particularly from periodontal infections or damaged oral tissues.
- Once in circulation, it may disseminate to distant sites, including the liver, brain, and lungs.
- Hematogenous spread can result in systemic infections and abscess formation, particularly in susceptible individuals.
Key point: F. nucleatum is primarily an oral commensal but can become an opportunistic pathogen when it gains access to normally protected tissues. Its ability to disseminate beyond the oral cavity and its association with colorectal and other diseases make it an important organism in both clinical microbiology and microbiome research.
Clinical Manifestations of Fusobacterium nucleatum
Oral and Dental Infections
- Gingivitis: Causes or contributes to gum inflammation, resulting in redness, swelling, tenderness, and bleeding.
- Periodontitis: Associated with destruction of the supporting tissues of the teeth, periodontal pocket formation, alveolar bone loss, and tooth mobility.
- Dental Plaque Formation: Participates in dental biofilm formation by promoting aggregation and interaction between different oral bacterial species.
- Periapical Abscesses: Can be involved in polymicrobial infections around the root of a tooth, leading to painful inflammation and accumulation of pus.
Head and Neck Infections
- Lemierre’s Syndrome: F. nucleatum can cause this serious infection, characterized by septic thrombophlebitis of the internal jugular vein, often following an oropharyngeal infection.
- Clinical manifestations may include sore throat, fever, fatigue, headache, tonsillar infection, swollen cervical lymph nodes, neck pain or swelling, nausea, vomiting, muscle aches, difficulty breathing or swallowing, and cough that may produce blood-streaked sputum.
- Severe cases may involve septic emboli, particularly affecting the lungs.
Systemic Infections
- Abscess Formation: Hematogenous dissemination may result in abscesses in organs such as the brain, liver, and lungs.
- Bacteremia and Sepsis: Entry of the bacterium into the bloodstream can cause bacteremia and, in severe cases, sepsis, particularly in individuals with underlying disease or impaired host defenses.
Gastrointestinal Infections and Disease
- Colorectal Cancer: F. nucleatum has been associated with colorectal tumor development and progression, potentially through inflammation, immune modulation, and altered cellular signaling.
- Appendicitis and Intra-abdominal Infections: The bacterium can be involved in polymicrobial intra-abdominal infections, including appendicitis.
Pregnancy-Related Infections
- F. nucleatum has been associated with adverse pregnancy outcomes, including:
- Premature or preterm birth
- Stillbirth
- Chorioamnionitis, an infection and inflammation involving the fetal membranes and placenta
Complications of Lemierre’s Syndrome
- Septic pulmonary emboli
- Pleural effusion — accumulation of fluid around the lungs
- Pneumonia
- Lung abscess
- Empyema — accumulation of pus in the pleural space between the lung and chest wall
- Septic arthritis — infection of a joint that can cause significant inflammation and tissue damage
Laboratory Diagnosis of Fusobacterium nucleatum
Sample Collection
- The type of specimen depends on the suspected site of infection.
- Oral and dental infections: Dental plaque scraping, gingival swab, periodontal pocket sample, or saliva.
- Head and neck infections: Throat swab, pus aspirate from a neck abscess, or tissue biopsy.
- Bloodstream infections: Blood sample.
- Systemic infections: Pus from an abscess, tissue biopsy, or sterile body fluids.
- Pregnancy-related infections: Amniotic fluid or placental tissue.
Microscopy
- Gram staining is useful for the preliminary identification of F. nucleatum.
- It appears as slender Gram-negative rods with tapered or pointed ends, producing a characteristic spindle-shaped appearance.
Culture
- Specimens are inoculated onto suitable enriched anaerobic media.
- Cultures are incubated under strict anaerobic conditions, generally at 37°C for 24–48 hours.
- Blood agar: Produces small, approximately 1–2 mm, round to slightly irregular, translucent, generally non-hemolytic colonies. A characteristic “fried-egg” appearance may be observed, along with a foul or rancid odor.
- Brain Heart Infusion (BHI) agar: Produces approximately 1–3 mm colonies that may be circular, irregular, or slightly lobate, with grayish-white to cream coloration. Colonies may have a smooth to slightly granular or bread-crumb-like surface and a soft or butyrous consistency.
- Thioglycollate broth: Produces diffuse turbidity with sedimentation toward the bottom of the broth.
Biochemical Tests
- Suspected colonies obtained after anaerobic culture can be evaluated using biochemical tests to support identification.
- Gram staining: Negative
- Catalase: Negative
- Oxidase: Negative
- Voges–Proskauer (VP): Negative
- Indole: Positive
- Motility: Negative
- Gas production: Positive
- Gelatin hydrolysis: Variable
- Nitrate reduction: Negative
- Methylene blue reduction: Positive
Serological Tests
- Serological methods can detect antibodies against F. nucleatum in saliva or serum.
- Detection of IgG antibodies may indicate previous or ongoing exposure.
- Because antibodies can persist after exposure or infection, serology generally cannot reliably distinguish active infection from previous exposure.
- It is therefore best interpreted alongside clinical findings and other laboratory investigations.
Molecular Methods
- Polymerase Chain Reaction (PCR): Detects F. nucleatum DNA and provides a rapid, sensitive, and specific method for detecting the bacterium.
- 16S rRNA Gene Sequencing: Provides accurate bacterial identification and is particularly useful in research and complex infections.
- Fluorescence In Situ Hybridization (FISH): Detects and localizes F. nucleatum within tissue samples, including colorectal cancer tissues.
- FISH can help demonstrate the spatial relationship between bacteria and tumor cells and determine whether bacteria are associated with or present within host cells.
- Immunohistochemistry (IHC): May be used with tissue-based methods to investigate the presence and localization of bacterial components in colorectal tumor tissues.
Fecal Immunochemical Test (FIT)
- FIT is a rapid and non-invasive test primarily used for colorectal cancer screening, rather than as a standalone test for F. nucleatum infection.
- When combined with microbial or bacterial biomarkers, fecal testing may be useful for investigating colorectal lesions and F. nucleatum-associated colorectal disease.
- Its diagnostic performance is limited and it should not replace established CRC diagnostic procedures, such as colonoscopy when clinically indicated.
Overall Diagnosis
- Identification of F. nucleatum is best achieved by combining specimen collection, Gram staining, anaerobic culture, colony characteristics, biochemical testing, and molecular methods where appropriate.
- Because F. nucleatum is a normal member of the oral microbiota and infections are often polymicrobial, laboratory results should always be interpreted together with the clinical presentation and site of infection.
Treatments of Fusobacterium nucleatum Infections
Antibiotic Therapy
Treatment depends on the site and severity of infection, antimicrobial susceptibility, and whether the infection is polymicrobial.
Commonly used antibiotics:
- Metronidazole: Provides effective anaerobic coverage and is frequently used against F. nucleatum.
- Amoxicillin: May be used for susceptible infections, particularly in oral infections.
- Clindamycin: An alternative option in selected patients with penicillin allergy, depending on susceptibility and local resistance patterns.
- Amoxicillin–clavulanate: Provides broader coverage and is useful when F. nucleatum occurs as part of a mixed oral or polymicrobial infection.
- Carbapenems (e.g., meropenem or imipenem): May be considered for severe or complicated infections, particularly when broad-spectrum coverage is required.
- Cephalosporin + metronidazole: May be used for certain systemic or intra-abdominal polymicrobial infections when broad aerobic and anaerobic coverage is needed.
Surgical Procedures
- Severe or deep-seated infections may require source control in addition to antibiotic therapy.
- Surgical management may include:
- Drainage or removal of abscesses involving the brain, head and neck, lungs, or other organs.
- Drainage of pleural fluid in complicated thoracic infections.
- Management of infected jugular-vein thrombosis when clinically indicated.
- Removal of infected or necrotic tissue.
- Drainage of deep neck-space infections when required.
- Tonsillectomy may occasionally be considered in selected recurrent or complicated cases but is not routinely performed in every case of Lemierre’s syndrome.
Dental Treatment
- Dental management is important when the infection originates from periodontal disease or an odontogenic source.
- Procedures may include:
- Professional scaling and plaque/calculus removal
- Root canal treatment for appropriate endodontic infections
- Tooth extraction when the tooth cannot be adequately treated or preserved
- Treatment of periodontal pockets and other sources of infection
Supportive Care
- Non-steroidal anti-inflammatory drugs (NSAIDs) or other appropriate analgesics may be used to control pain and fever.
- Adequate hydration and nutritional support are important, particularly in severe infections.
- Hospitalization and intravenous therapy may be necessary in patients with sepsis, deep organ abscesses, severe Lemierre’s syndrome, or other complicated systemic infections.
Treatment of Lemierre’s Syndrome
- Management generally requires prolonged antimicrobial therapy with strong anaerobic coverage, along with drainage or other source-control procedures when necessary.
- Antibiotics that may be used include:
- Amoxicillin–clavulanate
- Clindamycin
- Metronidazole-containing regimens
- Carbapenems such as imipenem, particularly in severe infections
- Treatment should be individualized according to the causative organism(s), susceptibility results, clinical severity, and anatomical site of infection.
- Anticoagulation may be considered in selected patients with Lemierre’s syndrome and internal jugular vein thrombosis, but its use is individualized and requires clinical assessment.
Pregnancy-Related Infections
- Treatment of suspected F. nucleatum infection during pregnancy requires obstetric and infectious-disease assessment.
- Antibiotics such as amoxicillin or clindamycin may be used when clinically appropriate and based on susceptibility and the site of infection.
- Antibiotic selection during pregnancy should consider gestational age, maternal condition, fetal considerations, allergy history, and antimicrobial susceptibility.
Prevention and Control of Fusobacterium nucleatum Infections
- Maintain good oral hygiene through regular tooth brushing and daily flossing to reduce dental plaque and periodontal inflammation.
- Antiseptic mouthwashes may be used when recommended by a dental professional as an adjunct to mechanical plaque control.
- Attend routine dental examinations to identify and manage periodontal disease at an early stage.
- Professional scaling and root planing can help remove dental plaque and calculus in patients with periodontal disease.
- Appropriate treatment of dental caries, periodontal infections, and other oral sources of infection can reduce the risk of invasive disease.
- Practice good hand and respiratory hygiene, particularly when dealing with individuals who have respiratory or oropharyngeal infections.
- Avoid sharing toothbrushes and other items that come into direct contact with saliva.
- Because F. nucleatum is also a normal component of the oral microbiota, complete avoidance of exposure is generally not realistic or necessary; prevention focuses primarily on maintaining oral health and promptly treating infections.
Conclusion
- Fusobacterium nucleatum is a Gram-negative, obligately anaerobic, spindle-shaped bacterium that normally inhabits the human oral cavity but can act as an opportunistic pathogen under certain conditions.
- It plays an important role in dental plaque development, polymicrobial biofilm formation, and periodontal diseases, including gingivitis and periodontitis.
- As a bridge organism, F. nucleatum facilitates adhesion and interactions between different bacterial species, contributing to the development and maturation of complex oral biofilms.
- Although primarily associated with the oral cavity, F. nucleatum can disseminate to extraoral sites and contribute to serious infections such as bacteremia, abscesses, and Lemierre’s syndrome.
- Its presence has also been associated with colorectal cancer and adverse pregnancy outcomes. However, these associations are complex, and the detection of F. nucleatum does not by itself establish direct causation.
- The pathogenic potential of F. nucleatum is largely related to its ability to adhere to host tissues, invade cells, form biofilms, promote inflammation, and modulate host immune responses.
- Treatment depends on the site, severity, and characteristics of the infection and may involve appropriate antimicrobial therapy, drainage of abscesses, and other source-control measures when required.
- Prevention primarily focuses on maintaining good oral hygiene, receiving regular dental care, managing periodontal disease, and treating oral infections promptly.
- Overall, F. nucleatum is an important organism in oral microbiology and systemic disease research because of its ability to connect microbial communities, interact with host tissues, and potentially contribute to disease beyond the oral cavity.
References
- Global Biodiversity Information Facility (GBIF). (n.d.). Fusobacterium nucleatum species page (Species ID: 165671650). Retrieved April 10, 2026, from GBIF
- Muchová, M. (2020). Characterisation of Fusobacterium nucleatum biofilms and the role of cyclic di-nucleotides [Master’s thesis, University of Birmingham]. University of Birmingham eTheses Repository. University of Birmingham eTheses Repository
- Leibniz Institute DSMZ—German Collection of Microorganisms and Cell Cultures GmbH. (n.d.). BacDive: The bacterial diversity metadatabase—Strain 5765. Retrieved April 10, 2026, from BacDive
- Aryal, S. (2022). Biochemical test of Fusobacterium necrophorum. Microbe Notes. Microbe Notes
- Groeger, S., Zhou, Y., Ruf, S., & Meyle, J. (2022). Pathogenic mechanisms of Fusobacterium nucleatum on oral epithelial cells. Frontiers in Oral Health, 3, 831607.
- Chen, Y., Shi, T., Li, Y., Huang, L., & Yin, D. (2022). Fusobacterium nucleatum: The opportunistic pathogen of periodontal and peri-implant diseases. Frontiers in Microbiology, 13, 860149.
- Hong, B.-Y., Chhaya, A., Robles, A., Cervantes, J., & Tiwari, S. (2024). The role of Fusobacterium nucleatum in the pathogenesis of colon cancer. Gastrointestinal Endoscopy Clinics of North America, 72(8), 819–827.
- PubMed. (2024). PubMed record for PMID 39175147. PubMed
- Nayak, S., Shetty, N. D., & Kamath, D. G. (2024). Commensalism of Fusobacterium nucleatum: The dilemma. Journal of Indian Society of Periodontology, 28(4), 427–430.
- Yang, X., Zhang, S., Ning, T., & Wu, J. (2025). Fusobacterium nucleatum in health and disease. MedComm, 6(11), e70465.
- Plata, A. F., Sanchez Najera, R. I., Lanas Ortiz, J. U., Chang, S. S., Sifuentes Casas, J. M., Muñuzuri Arana, H. L., Giles Lopez, J. F., Moreno Alvarado, Y., & Solis Soto, J. M. (2025). Fusobacterium nucleatum: Update on epidemiology, clinical manifestations, diagnosis and treatment. International Journal of Applied Dental Sciences, 11(2), 72–76.
- Cleveland Clinic. (2025, August 15). Lemierre’s syndrome: Causes, symptoms & treatment. Cleveland Clinic
- He, X., Zhao, Q., Zhang, J., Shi, J., Wan, N., Tang, B., Tian, B., & Li, P. (2025). Potential and application of Fusobacterium nucleatum in the diagnosis and treatment of colorectal cancer. Frontiers in Microbiology, 16, 1652702.
%20Explained%20Mechanisms,%20Evolutionary%20Fate,%202R%20Hypothesis%20and%20Polyploidy.webp)
